4-Boronophenylalanine-18F

N/A

Report date: 2026/04/14 20:00:15
NMEFirst In Class

Base Information

Drug Name4-Boronophenylalanine-18F
Drug Alias NameNBB-00218F-BPA
ClassificationDrug and medical devices combination productsSmall moleculesRadiation-emitting products > Radioactive diagnostic agent +[6] 
Mechanisms of ActionIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsDiagnostic agentsSolid tumoursHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNeuboron Medtech Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhongbo (Xiamen) Biomedical Co Ltd
Inactive CompaniesNeuboron Medtech Ltd
Active IndicationsDiagnostic agentsSolid tumoursHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A